VR for Cataract Anxiety Lowering Management--A RCT Study

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age20-90
SponsorShanghai General Hospital, Shanghai Jiao Tong University School of Medicine

About this trial

Cataract is currently the leading cause of blindness globally, and surgery is the only effective treatment. With the advancement of medical technology, cataract surgery is usually performed under topical anesthesia, which means patients will be awake during the procedure, able to see the light from the surgical lamp and hear the sounds of surgical instruments being operated. Some patients may feel nervous or scared due to unfamiliarity with the surgical process, which may lead to increased blood pressure, rapid heartbeat, and even affect their cooperation during the surgery.Virtual reality (VR) technology is a new multimedia technology. By wearing VR glasses, patients can immerse themselves in a virtual world and see and hear realistic scenes. Through this study, the investigators aim to investigate whether allowing cataract patients to "experience" a surgical procedure in advance through VR glasses before cataract surgery can help alleviate their nervousness during the actual surgery.

Eligibility criteria

Qualifiers

Diagnosed with cataracts in one or both eyes, and planning to undergo surgical treatment

Voluntarily participate in this trial and sign the informed consent form.

Disqualifiers

History of previous ophthalmic surgery

Suffering from severe hearing impairment, unable to comprehend VR video content.

Those who suffer from cognitive dysfunction or mental illness and are unable to cooperate in completing the scale assessment.

Suffering from severe macular diseases, glaucoma, or other ocular diseases that may affect surgery or interfere with the assessment of tension level.

Trial design

Treatments tested in this trial

  • Virtual reality simulation of intraoperative audiovisual experience

Treatment groups

260 Participants
are divided into 2 treatment groups

Locations

This trial has no locations